<DOC>
	<DOCNO>NCT02426697</DOCNO>
	<brief_summary>The clinical trial stage 3 study determine role fentanyl transmucosal prevention pain induced mobilization patient receive bone metastasis radiation bone metastasis irradiation</brief_summary>
	<brief_title>Pain Management With Pecfent Prevention Pain Induced Position Radiotherapy</brief_title>
	<detailed_description>Participation trial propose patient investigator charge analgesic irradiation preliminary scanner session hold radiotherapy session ( ) . Patients VAS≤ 3 exclude . PecFent Placebo deliver Archimedes Pharma When start radiotherapy session ( ) ( 2 day preliminary scanner session ) , medic collect patient sign informed consent , deliver treatment 1 dose fentanyl transmucosal ( Pecfent® ) 100µg naive patient 1 dose Pecfent® 200µg patient stable opioid background pain treatment placebo ) collect pain intensity value patient VAS collect end radiotherapy session . Finally patient &amp; radiotherapist global satisfaction collect An assessment week end radiotherapy session assess investigator consist Patient global satisfaction Study follow : Patients receive phone call week radiotherapy session collect patient global satisfaction score relate global management radiotherapy session</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Male female More 18 year old Proven histological cancer bone metastasis SignedInform consent form Patient pain assed VAS Superior 3 position patient preliminary scanner session VAS &gt; 3 radiotherapy treatment ( establishment appropriate analgesic treatment ) ( session Any SAO treatment go Pregnant lactate woman Hypersensitivity safety issue opioïd treatment Poor nasal mucosa ( defined clinical doctor assessment ) Severe obstructive lung condition respiratory depression Renal insufficiency creatinine clearance inferior 45 ml/min Hepatic insufficiency Patient misunderstanding content objective trial Patient supervision guardianship SAO intake 4 hour radiotherapy session Patient participate pain management trial Morphine pump usage</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>bone metastasis , radiotherapy , pain , prevention</keyword>
</DOC>